US Stock MarketDetailed Quotes

CYCCP Cyclacel Pharmaceuticals Inc

Watchlist
  • 6.100
  • 0.0000.00%
Close Nov 12 16:00 ET
73.18MMarket Cap0.00P/E (TTM)

Cyclacel Pharmaceuticals Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-98.93%4K
29K
420K
31K
16K
373K
0
0
0
0
Operating revenue
-98.93%4K
--29K
--420K
--31K
--16K
--373K
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-42.11%3.65M
-40.10%4.38M
-6.45%25.87M
-39.05%5.39M
6.09%6.86M
8.94%6.3M
11.59%7.32M
23.52%27.66M
47.79%8.85M
7.82%6.47M
Selling and administrative expenses
3.17%1.63M
-3.83%1.58M
-8.99%6.72M
-12.60%1.87M
-20.89%1.63M
-0.32%1.58M
2.49%1.65M
-1.06%7.38M
10.41%2.14M
15.33%2.05M
-General and administrative expense
3.17%1.63M
-3.83%1.58M
-8.99%6.72M
-12.60%1.87M
-20.89%1.63M
-0.32%1.58M
2.49%1.65M
-1.06%7.38M
10.41%2.14M
15.33%2.05M
Research and development costs
-57.20%2.02M
-50.62%2.8M
-5.52%19.16M
-47.51%3.52M
18.65%5.24M
12.41%4.73M
14.53%5.67M
35.81%20.27M
65.73%6.7M
4.65%4.41M
Operating profit
38.54%-3.64M
40.50%-4.36M
7.97%-25.45M
39.40%-5.36M
-5.85%-6.85M
-2.49%-5.93M
-11.59%-7.32M
-23.52%-27.66M
-47.79%-8.85M
-7.82%-6.47M
Net non-operating interest income expense
-136.36%-28K
-98.28%2K
26.67%266K
-81.15%23K
-25.37%50K
352.94%77K
2,800.00%116K
1,212.50%210K
2,950.00%122K
1,575.00%67K
Non-operating interest income
----
-98.28%2K
26.67%266K
-81.15%23K
-25.37%50K
352.94%77K
2,800.00%116K
1,212.50%210K
2,950.00%122K
1,575.00%67K
Non-operating interest expense
--28K
----
----
----
----
----
----
----
----
----
Other net income (expense)
101.65%3K
-32.91%53K
-123.78%-364K
-28.52%-356K
-67.24%95K
-187.08%-182K
-93.96%79K
714.36%1.53M
-810.26%-277K
3,122.22%290K
Gain on sale of security
103.95%3K
101.15%1K
-277.68%-414K
-26.69%-356K
-62.32%104K
-136.36%-76K
-400.00%-87K
429.55%233K
-820.51%-281K
2,966.67%276K
Other non- operating income (expenses)
----
-68.67%52K
-96.15%50K
--0
-164.29%-9K
---106K
-87.03%166K
801.39%1.3M
--4K
--14K
Income before tax
39.19%-3.67M
39.64%-4.3M
1.40%-25.55M
36.74%-5.69M
-9.66%-6.7M
-8.54%-6.03M
-35.80%-7.12M
-16.81%-25.92M
-51.46%-9M
-2.09%-6.11M
Income tax
29.69%-412K
-2.58%-1.35M
36.49%-3M
73.31%-422K
34.12%-668K
40.45%-586K
-15.99%-1.32M
-26.53%-4.72M
-46.66%-1.58M
-1.60%-1.01M
Net income
40.22%-3.26M
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
-2.19%-5.1M
Net income continuous Operations
40.22%-3.26M
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
-2.19%-5.1M
Minority interest income
Net income attributable to the parent company
40.22%-3.26M
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
-2.19%-5.1M
Preferred stock dividends
0.00%201K
0.00%50K
0.00%50K
0.00%50K
0.00%50K
0.00%201K
0.00%50K
0.00%50K
Other preferred stock dividends
Net income attributable to common stockholders
40.76%-3.26M
49.68%-2.95M
-6.34%-22.76M
28.76%-5.32M
-18.19%-6.08M
-18.88%-5.5M
-40.79%-5.85M
-14.69%-21.4M
-51.99%-7.47M
-2.16%-5.15M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -98.93%4K29K420K31K16K373K0000
Operating revenue -98.93%4K--29K--420K--31K--16K--373K--0--0--0--0
Cost of revenue
Gross profit
Operating expense -42.11%3.65M-40.10%4.38M-6.45%25.87M-39.05%5.39M6.09%6.86M8.94%6.3M11.59%7.32M23.52%27.66M47.79%8.85M7.82%6.47M
Selling and administrative expenses 3.17%1.63M-3.83%1.58M-8.99%6.72M-12.60%1.87M-20.89%1.63M-0.32%1.58M2.49%1.65M-1.06%7.38M10.41%2.14M15.33%2.05M
-General and administrative expense 3.17%1.63M-3.83%1.58M-8.99%6.72M-12.60%1.87M-20.89%1.63M-0.32%1.58M2.49%1.65M-1.06%7.38M10.41%2.14M15.33%2.05M
Research and development costs -57.20%2.02M-50.62%2.8M-5.52%19.16M-47.51%3.52M18.65%5.24M12.41%4.73M14.53%5.67M35.81%20.27M65.73%6.7M4.65%4.41M
Operating profit 38.54%-3.64M40.50%-4.36M7.97%-25.45M39.40%-5.36M-5.85%-6.85M-2.49%-5.93M-11.59%-7.32M-23.52%-27.66M-47.79%-8.85M-7.82%-6.47M
Net non-operating interest income expense -136.36%-28K-98.28%2K26.67%266K-81.15%23K-25.37%50K352.94%77K2,800.00%116K1,212.50%210K2,950.00%122K1,575.00%67K
Non-operating interest income -----98.28%2K26.67%266K-81.15%23K-25.37%50K352.94%77K2,800.00%116K1,212.50%210K2,950.00%122K1,575.00%67K
Non-operating interest expense --28K------------------------------------
Other net income (expense) 101.65%3K-32.91%53K-123.78%-364K-28.52%-356K-67.24%95K-187.08%-182K-93.96%79K714.36%1.53M-810.26%-277K3,122.22%290K
Gain on sale of security 103.95%3K101.15%1K-277.68%-414K-26.69%-356K-62.32%104K-136.36%-76K-400.00%-87K429.55%233K-820.51%-281K2,966.67%276K
Other non- operating income (expenses) -----68.67%52K-96.15%50K--0-164.29%-9K---106K-87.03%166K801.39%1.3M--4K--14K
Income before tax 39.19%-3.67M39.64%-4.3M1.40%-25.55M36.74%-5.69M-9.66%-6.7M-8.54%-6.03M-35.80%-7.12M-16.81%-25.92M-51.46%-9M-2.09%-6.11M
Income tax 29.69%-412K-2.58%-1.35M36.49%-3M73.31%-422K34.12%-668K40.45%-586K-15.99%-1.32M-26.53%-4.72M-46.66%-1.58M-1.60%-1.01M
Net income 40.22%-3.26M49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M-2.19%-5.1M
Net income continuous Operations 40.22%-3.26M49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M-2.19%-5.1M
Minority interest income
Net income attributable to the parent company 40.22%-3.26M49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M-2.19%-5.1M
Preferred stock dividends 0.00%201K0.00%50K0.00%50K0.00%50K0.00%50K0.00%201K0.00%50K0.00%50K
Other preferred stock dividends
Net income attributable to common stockholders 40.76%-3.26M49.68%-2.95M-6.34%-22.76M28.76%-5.32M-18.19%-6.08M-18.88%-5.5M-40.79%-5.85M-14.69%-21.4M-51.99%-7.47M-2.16%-5.15M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data